Reports Q3 revenue $96.06M, consensus $95.64M. “A strong balance sheet and disciplined cost-management underpin our focused business execution,” said Emily Leproust, CEO and co-founder of Twist Bioscience (TWST).
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TWST: